175 related articles for article (PubMed ID: 24861922)
1. Expression and correlation of matrix metalloproteinase-9 and heparanase in patients with breast cancer.
Tang D; Piao Y; Zhao S; Mu X; Li S; Ma W; Song Y; Wang J; Zhao W; Zhang Q
Med Oncol; 2014 Jul; 31(7):26. PubMed ID: 24861922
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer.
Wu ZS; Wu Q; Yang JH; Wang HQ; Ding XD; Yang F; Xu XC
Int J Cancer; 2008 May; 122(9):2050-6. PubMed ID: 18172859
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer.
Zhang B; Cao X; Liu Y; Cao W; Zhang F; Zhang S; Li H; Ning L; Fu L; Niu Y; Niu R; Sun B; Hao X
BMC Cancer; 2008 Mar; 8():83. PubMed ID: 18373849
[TBL] [Abstract][Full Text] [Related]
4. The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer.
Tang D; Zhang Q; Zhao S; Wang J; Lu K; Song Y; Zhao L; Kang X; Wang J; Xu S; Tian L
Clin Biochem; 2013 Jul; 46(10-11):926-32. PubMed ID: 23415719
[TBL] [Abstract][Full Text] [Related]
5. Clinical value of combined detection of serum matrix metalloproteinase-9, heparanase, and cathepsin for determining ovarian cancer invasion and metastasis.
Zhang W; Yang HC; Wang Q; Yang ZJ; Chen H; Wang SM; Pan ZM; Tang BJ; Li QQ; Li L
Anticancer Res; 2011 Oct; 31(10):3423-8. PubMed ID: 21965756
[TBL] [Abstract][Full Text] [Related]
6. Serum levels of matrix metalloproteinase-9 predict lymph node metastasis in breast cancer patients.
Heo DS; Choi H; Yeom MY; Song BJ; Oh SJ
Oncol Rep; 2014 Apr; 31(4):1567-72. PubMed ID: 24481627
[TBL] [Abstract][Full Text] [Related]
7. Serum and tissue expression of gelatinase and Twist in breast cancer.
Huang J; Ang L; Liu MQ; Hu HG; Wang J; Zou Q; Zhao Y; Zheng L; Zhao M; Wu ZS
Eur Rev Med Pharmacol Sci; 2014; 18(18):2662-9. PubMed ID: 25317801
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between the expression of matrix metalloproteinase-13 protein and other biomarkers, prognosis in invasive breast cancer].
Zhang B; Liu YX; Cao WF; Cao XC; Ning LS; Hao XS
Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):471-6. PubMed ID: 19035119
[TBL] [Abstract][Full Text] [Related]
9. A Marine λ-Oligocarrageenan Inhibits Migratory and Invasive Ability of MDA-MB-231 Human Breast Cancer Cells through Actions on Heparanase Metabolism and MMP-14/MMP-2 Axis.
Cousin R; Groult H; Manseur C; Ferru-Clément R; Gani M; Havret R; Toucheteau C; Prunier G; Colin B; Morel F; Piot JM; Lanneluc I; Baranger K; Maugard T; Fruitier-Arnaudin I
Mar Drugs; 2021 Sep; 19(10):. PubMed ID: 34677445
[TBL] [Abstract][Full Text] [Related]
10. Expression of metalloproteinases MMP-2 and MMP-9 in sentinel lymph node and serum of patients with metastatic and non-metastatic breast cancer.
Daniele A; Zito AF; Giannelli G; Divella R; Asselti M; Mazzocca A; Paradiso A; Quaranta M
Anticancer Res; 2010 Sep; 30(9):3521-7. PubMed ID: 20944132
[TBL] [Abstract][Full Text] [Related]
11. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma.
Zhang S; Li L; Lin JY; Lin H
World J Gastroenterol; 2003 May; 9(5):899-904. PubMed ID: 12717827
[TBL] [Abstract][Full Text] [Related]
12. The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph node-negative untreated breast cancer patients.
Milovanovic J; Todorovic-Rakovic N; Abu Rabi Z
J BUON; 2013; 18(4):866-73. PubMed ID: 24344010
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Derived Matrix Metalloproteinase-13 (MMP-13) Expression in Benign and Malignant Breast Lesions.
Ameli F; Ghafourina Nassab F; Masir N; Kahtib F
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2603-2609. PubMed ID: 34452576
[TBL] [Abstract][Full Text] [Related]
14. Significance of MMP-9 and VEGF-C expression in North Indian women with breast cancer diagnosis.
Thammineni KL; Thakur GK; Kaur N; Banerjee BD
Mol Cell Biochem; 2019 Jul; 457(1-2):93-103. PubMed ID: 30993496
[TBL] [Abstract][Full Text] [Related]
15. Expression and clinical significance of matrix metalloproteinase-9 in lymphatic invasiveness and metastasis of breast cancer.
Wu QW; Yang QM; Huang YF; She HQ; Liang J; Yang QL; Zhang ZM
PLoS One; 2014; 9(5):e97804. PubMed ID: 24845596
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2 (MMP-2) and MMP-9 expression in invasive ductal carcinoma of the breast.
Sullu Y; Demirag GG; Yildirim A; Karagoz F; Kandemir B
Pathol Res Pract; 2011 Dec; 207(12):747-53. PubMed ID: 22030137
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of heparanase and matrix metalloproteinase-9 in patients with cutaneous malignant melanoma.
Chen Y; Chen Y; Huang L; Yu J
J Dermatol; 2012 Apr; 39(4):339-43. PubMed ID: 22150440
[TBL] [Abstract][Full Text] [Related]
18. Newly generated heparanase knock-out mice unravel co-regulation of heparanase and matrix metalloproteinases.
Zcharia E; Jia J; Zhang X; Baraz L; Lindahl U; Peretz T; Vlodavsky I; Li JP
PLoS One; 2009; 4(4):e5181. PubMed ID: 19360105
[TBL] [Abstract][Full Text] [Related]
19. Expression of heparanase by primary breast tumors promotes bone resorption in the absence of detectable bone metastases.
Kelly T; Suva LJ; Huang Y; Macleod V; Miao HQ; Walker RC; Sanderson RD
Cancer Res; 2005 Jul; 65(13):5778-84. PubMed ID: 15994953
[TBL] [Abstract][Full Text] [Related]
20. Plasma MMP-9 (92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients.
Ranuncolo SM; Armanasco E; Cresta C; Bal De Kier Joffe E; Puricelli L
Int J Cancer; 2003 Sep; 106(5):745-51. PubMed ID: 12866035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
